AVA-1156

N/A

Report date: 2025/06/11 11:20:04

Base Information

Drug NameAVA-1156
Drug Alias Nameglycolipid-peptide conjugate vaccine (Avalia Immunotherapies)AVA-1025AVA-1001AVA-1156
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionNatural killer T-lymphocyte stimulantsProtein E7 modulators
TargetsProtein E7
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNew Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAvalia Immunotherapies Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAvalia Immunotherapies Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A